Venus Remedies Ltd Locks at Upper Circuit With 5% Gain — Buyers Queue, Sellers Absent

Circuit Event and Unfilled Demand

The stock, trading in the BE series, hit its upper circuit price band of 5%, closing at Rs 1,647.10 after opening at the same level. This price band capped the maximum daily gain allowed, effectively freezing trading at the ceiling price. The total traded volume was 46,758 shares, with a turnover of approximately Rs 7.61 crore. The narrow intraday range — from Rs 1,530.30 to Rs 1,647.10 — reflects the circuit lock, where demand exceeded what the price band could accommodate, leaving unfilled buy orders on the book. Venus Remedies Ltd’s session illustrates how the exchange ceiling stopped the rally, not the buyers.

Delivery and Volume Analysis

Delivery volumes provide the clearest insight into the quality of this upper circuit move. On 11 Aug 2026, the delivery volume surged by 83.96% compared to the 5-day average, reaching 4,140 shares. This rise in delivery volume indicates that the shares traded were largely taken into investors’ demat accounts, signalling genuine buying conviction rather than intraday speculative trading. Volume on a circuit day is mechanically suppressed due to the price lock, so the delivery component is the most revealing metric — is this surge in delivery volume a sign of sustained interest or a short-term momentum spike? The total traded volume, while lower than usual, is consistent with the circuit mechanism and does not detract from the conviction signal.

Moving Averages and Trend Context

Venus Remedies Ltd currently trades above its 5-day, 20-day, 100-day, and 200-day moving averages, though it remains slightly below the 50-day moving average. This positioning suggests a predominantly bullish trend with some short-term resistance near the 50-day level. The upper circuit day further confirms the positive momentum, as the stock added 5% to its price while maintaining a position above most key technical levels. The 5% price band capped the gain, but the trend structure was already supportive — does this technical setup indicate a breakout or a temporary peak?

Liquidity and Market Capitalisation Context

With a market capitalisation of Rs 2,173 crore, Venus Remedies Ltd is classified as a micro-cap stock. The liquidity profile is moderate, with the stock liquid enough to support a trade size of approximately Rs 0.18 crore based on 2% of the 5-day average traded value. While this level of liquidity is reasonable for a micro-cap, it still implies limited institutional-grade liquidity and a relatively thin order book. This thinness can amplify price moves and circuit hits, making it difficult for larger investors to enter or exit positions without impacting the price. The upper circuit is impressive, but the ability to transact meaningful volumes remains constrained, highlighting the liquidity risk inherent in such stocks.

Intraday Price Action

The intraday price action was tightly constrained by the circuit mechanism. The stock opened at Rs 1,647.10 and traded at this price for the majority of the session, touching a low of Rs 1,530.30 earlier in the day. This narrow range near the upper circuit price is typical for stocks locked at the ceiling, where the absence of sellers prevents any downward movement. The lack of price fluctuation after the initial gap up reflects strong buying interest that was unmet by supply, reinforcing the unfilled demand narrative.

Fundamental Context

Venus Remedies Ltd operates in the Pharmaceuticals & Biotechnology sector, a space characterised by steady demand and innovation-driven growth. While the stock’s micro-cap status means it is more susceptible to volatility, its recent price action aligns with sector outperformance, as the stock gained 5.0% compared to the sector’s marginal decline of 0.07% and the Sensex’s fall of 0.39% on the same day. This relative strength adds a layer of fundamental support to the technical momentum observed.

Conclusion: What the Circuit and Data Signal

The upper circuit hit at Rs 1,647.10 with a 5% gain capped by the price band reflects strong buying pressure that exceeded available supply. The significant rise in delivery volumes on the previous day supports the view that this move is backed by genuine investor conviction rather than mere speculative trading. The stock’s position above most moving averages further confirms a bullish trend, while the micro-cap status and moderate liquidity highlight the risks associated with thin order books and limited trade sizes. This liquidity constraint means that while the momentum is clear, investors should be mindful of the challenges in entering or exiting sizeable positions in Venus Remedies Ltd. After a 5% single-day gain at upper circuit, is Venus Remedies Ltd still worth considering or has the move already happened?

Get 33% Off on our 1 Year Plan - Limited Period Only! Start Today